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Insulin-Secreting Pancreatic (Islet Cell) 
Carcinoma in a Cat 
Darren Hawks, DVM, Mark E. Peterson, DVM, 
Kathleen L. Hawkins, DVM, and Wendy S. Rosebury 
A functional, insulin-secreting pancreatic (islet cell) carcinoma was diagnosed in a 17-year-old male 
Siamese cat. Diagnosis was made on the basis of clinical signs (i.e., seizures and stupor) that resolved 
temporarily after correction of hypoglycemia with feeding or intravenous administration of glucose, the 
finding of an inappropriately increased serum insulin concentration in the face of hypoglycemia, and 
prolonged resolution of hypoglycemia after surgical removal of the tumor. Primary islet cell tumor of the 
pancreas was confirmed by biopsy. The cat died 18 months later, and necropsy revealed metastases to 
regional lymph nodes and liver. Specimens of the tumor and metastatic lesions both stained positively for 
insulin. (Journal of Veterinary Internal Medicine 1992; 193-196) 
INSULIN-SECRETING pancreatic (islet cell) tumors 
leading to hypoglycemia are well recognized in human 
beings,’ dogs,*-’ and ferrets,6 but they have not been well 
documented in cats. This report describes the clinical, 
serum biochemical, and pathologic findings in an elderly 
cat with an insulin-secreting tumor of the pancreas. 
Materials and Methods 
Serum insulin was measured with a commercial radioim- 
munoassay kit.* Assay of serial dilutions of a feline 
serum pool containing increased insulin concentrations 
(approximately 400 pmol/L) resulted in inhibition 
curves with slopes parallel with the standard curve. Accu- 
racy was determined by adding various quantities of puri- 
fied pork regular insulin to a feline serum pool contain- 
ing an undetectable concentration of insulin; analysis of 
the resulting data revealed an average recovery of 94%. 
The sensitivity of the insulin assay was 35 pmol/L. The 
intra- and interassay coefficients of variation were 8.1% 
and 1476, respectively. 
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Immunocytochemical staining was done with the 
avidin-biotin-peroxidase complex immunoperoxidase 
method as previously described,’.* with polyclonal anti- 
bodies against guinea pig insulin,t porcine glucagon,? 
human gastrin,? pancreatic polypeptide,? and somato- 
statin? and bovine neuron specific enolase,? and chro- 
mogranin A.S 
Case Report 
A 17-year-old male castrated Siamese cat was examined 
because of previously diagnosed hypoglycemic seizures. 
The seizures were grand mal, unassociated with meals, 
and responsive to oral corn syrup. The seizures had be- 
gun 18 months previously and were increasing in fre- 
quency. 
Three and 1 1 months before examination, the cat had 
two episodes of severe regenerative anemia (PCV 
= <lo%). Tests for FeLV, FIP, toxoplasmosis, and he- 
mobartonella were negative. During hospitalization for 
the second episode of anemia, the cat was found in a 
stupor with a blood glucose concentration of 25 mg/dl 
(normal, 70-1 50 mg/dl). The cat responded well to intra- 
venous administration of dextrose, and was discharged 
with instructions to the owner to feed frequently and to 
administer corn syrup as needed to control the seizures. 
Prednisone (5 mg, once daily, orally) was also given for 1 
month. During prednisone administration, the seizures 
decreased in frequency and severity but then increased 
t Dako Corp., Carpinteria, CA. 
$ Incstar Corp., Stillwater, MN. 
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to two or three seizures per week. Two weeks before ex- 
amination, at the time of one of the seizures, determina- 
tion of serum glucose and insulin concentrations by the 
refemng veterinarian revealed moderate hypoglycemia 
(50 mg/dl) with severe hyperinsulinemia (900 pmol/L; 
normal serum insulin = 35-220 pmol/L).§ 
On physical examination, the cat was weak, depressed, 
and hypothermic (temperature, 37.4 C). Severe hypogly- 
cemia was confirmed (blood glucose, 18 mg/dl) and the 
cat’s weakness and depression resolved immediately 
after feeding. The serum insulin concentration again was 
increased (250 pmol/L). Abdominal and thoracic radio- 
graphs were unremarkable, but abdominal ultrasonogra- 
phy showed a 1-cm mass in the angle of the pancreas 
adjacent to the portal vein. There was no evidence of 
metastasis to the liver or mesenteric lymph nodes. These 
findings were consistent with a diagnosis of insulin-se- 
creting pancreatic (islet cell) tumor. 
Exploratory laparotomy was completed, and a soli- 
tary, 1-cm in diameter, pale, nodular mass was excised 
from the angle of the pancreas between the portal vein 
and the pancreatic duct. No metastic tumor was seen in 
the liver or regional lymph nodes. Blood glucose concen- 
trations remained normal during and several days after 
surgery, despite discontinuation of dextrose administra- 
tion. The serum concentrations of insulin (140 pmol/L) 
and glucose ( 150 mg/dl) were normal 10 days after sur- 
gery. 
On histologic examination, the mass was consistent in 
appearance with an islet cell carcinoma. It was com- 
posed of a monomorphic population of round to oval 
cells with abundant, pale, finely granular eosinophilic 
cytoplasm and round to oval vesicular nuclei. Mitotic 
figures were uncommon, and tumor cells were subdi- 
vided into small nests and islands by a delicate fibrovas- 
cular stroma. The tumor was partially encapsulated and 
caused mild compression of the surrounding exocrine 
parenchyma. Metastasis was not observed on examina- 
tion of submitted liver sections. Immunocytochemical 
staining of the tumor revealed diffuse positive staining 
for insulin, neuron specific enolase, and chromogranin 
A, with rare, scattered cells staining positively for gluca- 
gon and somatostatin. 
At the 6-month reexamination, the cat was clinically 
normal and had normal serum concentrations of glucose 
(70 mg/dl) and insulin (200 pmol/L). Ten months after 
surgery, the cat began to have grand ma1 seizures again. 
At that time, determination of paired serum glucose and 
insulin concentrations again revealed hypoglycemia (46 
mg/dl) and hyperinsulinemia (357 pmol/L), consistent 
with a recurrent insulin-secreting tumor of the pancreas. 
The owner resumed administration of prednisone ( 5  mg, 
§ To convert from pmol/L to mIU/ml, divide given value by 7.18. 
once to twice daily, orally) and corn syrup and frequent 
feedings, but intermittent seizures continued. 
At 18 months, the cat developed anorexia, ataxia, and 
was described as dazed by the owner. Results of serum 
biochemical analysis revealed increased values for ala- 
nine aminotransferase ( 1  870 IU/L; normal = 5-75 IU/ 
L), aspartate aminotransferase (1000 IU/L; normal = 5- 
60 IU/L), alkaline phosphatase (1 6 1 IU/L; normal = 1- 
70 IU/L, total bilirubin (1.2 mg/dl; normal = 0.1-0.6 
mg/dl), and amylase (5880 IU/L; normal = <3000 IU/ 
L). Hypoglycemia (54 mg/dl) and hyperinsulinemia 
(240 pmol/L) were again present. The cat initially re- 
sponded to supportive treatment (i.e., subcutaneous 
fluids), but was found dead in the cage on the third day of 
hospitalization. 
Results of necropsy revealed metastases to the pancre- 
atic lymph nodes and liver. Histopathologic examina- 
tion revealed that the metastatic lesions were similar in 
appearance to the primary tumor, and results of immu- 
nocytochemical staining revealed diffuse positive stain- 
ing for insulin, neuron specific enolase, and chromo- 
granin A, with rare cells staining positively for pancreatic 
polypeptide, somatostatin, and glucagon (Figs. 1,2). Ex- 
amination of liver also revealed severe, diffuse, suppura- 
tive, chronic-active cholangiohepatitis with bridging 
portal fibrosis and bile stasis. Moderate diffuse chronic- 
active pancreatitis, with marked fibrosis and nodular hy- 
perplasia of the exocrine pancreas, was also observed. 
FIG. 1 .  Section of lymph node containing metastatic islet cell tumor. 
Immunohistochemical stain with anti-insulin (X 160). Note the immu- 
noreactive tumor cells with positive cytoplasmic staining. 
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FIG. 2. Section of lymph node containing metastatic islet cell tumor. 
Immunohistochemical stain with anti-chromogranin A (X256). 
Discussion 
Functional, insulin-secreting islet cell neoplasms of the 
pancreas (i.e., insulinomas) have been reported in hu- 
man beings and a variety of domestic animals.'-6 Insu- 
linomas are the most frequently reported pancreatic en- 
docrine neoplasm in people, the vast majority (90%) of 
which are benign (adenomas).' Similarly, insulin-secret- 
ing tumors are the most common islet cell tumor in 
dogs, but, in contrast to humans, most are malignant 
(carcinomas), and approximately half metastasize to the 
regional lymph nodes and l i ~ e r . ~ - ~  In cats, insulin-secret- 
ing pancreatic (islet cell) tumors are rare and have not 
been well characterized. Only three have been confirmed 
by histopathologic findings, in addition to clinical and 
biochemical evidence of hypoglycemia.'-" In one of 
these cats, a 12-year-old Siamese, severe hypoglycemia 
(20 mg/dl) and seizures resolved after surgical removal 
of a 1-cm islet cell tumor.9 However, clinical signs asso- 
ciated with hypoglycemia recurred 6 days after surgery, 
suggesting the presence of residual insulin-secreting tu- 
mor. The owners refused further treatment, and the cat 
died of seizures 5 weeks after surgery; necropsy was not 
allowed. The second cat, a 16-year-old domestic long- 
hair, had clinical signs of weight loss, polydipsia, and loss 
of appetite. lo Physical examination revealed a large, cra- 
nial abdominal mass, and laboratory testing showed hy- 
poglycemia (3  1 mg/dl). Surgical excision of a large nodu- 
lar mass involving the right limb of the pancreas was 
attempted, but the cat developed cardiac arrest and died. 
Histopathologic examination revealed a ductal pancre- 
atic adenocarcinoma, as well as two small islet cell tu- 
mors, 0.5 and 0.7 cm in diameter. Immunocytochemical 
staining of the islet cell tumors was positive for insulin in 
many cells, with fewer glucagon-containing cells." The 
third cat, a 14-year-old Siamese, had a 4-month history 
of episodic staggering and leg and facial twitching." Lab- 
oratory testing revealed mild hypoglycemia (59 mg/dl) 
and hyperinsulinemia, and intravenous glucose toler- 
ance testing showed delayed and exaggerated insulin se- 
cretion. Surgical removal of a 2-cm mass from the left 
lobe of the pancreas resulted in clinical remission of hy- 
poglycemia for 7 months. Histopathologic examination 
revealed a malignant pancreatic tumor, and immunocy- 
tochemical staining was positive for insulin in more than 
50% of the cells, with less than 10% of the tumor cells 
positive for somatostatin and islet amyloid polypep- 
tide." 
In our cat, the diagnosis of insulin-secreting pancreatic 
(islet cell) tumor was made on the basis of the following: 
1) neurologic signs (i.e., seizures and stupor) associated 
with severe hypoglycemia; 2) temporary relief of clinical 
signs after correction of hypoglycemia with feeding or 
intravenous administration of glucose; 3) the finding of 
an inappropriately increased serum insulin concentra- 
tion in the face of hypoglycemia on numerous occasions; 
4) prolonged resolution of neurologic signs (i.e., convul- 
sions) after surgical removal of the primary tumor, with 
concurrent normalization of serum glucose and insulin 
concentrations; and finally, 5 )  histologic confirmation of 
a pancreatic islet cell carcinoma with metastases to re- 
gional lymph nodes and liver, both ofwhich stained posi- 
tively for insulin as well as for neuron specific enolase 
and chromogranin A, two immunohistochemical 
markers for normal and neoplastic cells of neuroendo- 
crine 0rigin.'3~ As in this case, most islet cell tumors in 
humans and dogs are multihormonal when examined by 
immunocytochemical staining, but clinical signs due to 
oversecretion of one hormone usually pred~minate.~ 
Early in the course of illness, the cat developed severe 
regenerative anemia on two occasions. The cause of this 
anemia was not determined, and it is not known if the 
anemia was in any way related to the insulin-secreting 
pancreatic (islet cell) tumor. Anemia certainly is not a 
finding associated with insulinomas in human patients 
or  dog^.',^,^ However, after surgical removal of the pri- 
mary islet cell tumor, recurrence of the anemia was not 
observed during the final 18 months of the cat's life. 
Treatment of insulin-secreting pancreatic (islet cell) 
tumor may include medical management, surgcal exci- 
sion, or both. In our cat, frequent feedings and daily 
administration of glucocorticoids, which act to increase 
hepatic gluconeogenesis and decrease tissue utilization 
of glucose, helped control hypoglycemia and associated 
clinical signs, but surgical removal of the primary islet 
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cell tumor successfully controlled the hypoglycemia for 
months. As in dogs with islet cell carcinoma, in which 
tumor regrowth and metastases and return of clinical 
signs of neuroglycopenia are almost ine~i tab le ,~ .~ .~  recur- 
rence developed in this cat 10 months postoperatively, 
and metastases to the regional lymph nodes and liver 
were documented at necropsy. 
The cause of death in this cat is unclear, but was likely 
related to the cat’s severe cholangiohepatitis and chronic 
pancreatitis, rather than to complications of the islet cell 
carcinoma. Although the pancreatitis might have been 
related to the previous pancreatic surgery, the long inter- 
val between surgery and death in this cat make this less 
likely. The pancreatitis may have been related to the 
liver disease since a frequent coincidence of cholangio- 
hepatitis and pancreatic disease has been reported in 
cats.I2 
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